Companies related to inflammatory diseases

We solve medical challenges with innovative technology.

We are a biotech company focused on developing precision medicines for neurological and immunological diseases.

Pharmaceutical group developing prescribed medicines based on synthetic cannabinoid acids to meet patient needs.

Dedicated scientists, clinicians and innovators, focused on improving the lives of patients with inflammatory diseases.

We conduct world-class, collaborative, biological research and translate discoveries for the benefit of patients.

Fate can be altered.

Develop human organ models with true physiological complexity

Developing novel diagnostics compact devices to enable hospitals a better stratification of sepsis in patients.

A better health accessible to all patients

Regulating Inflammation - through the nervous system

Unlocking targeted medicines with our transformative mRNA platform

Translating NET biology into novel therapies for inflammatory diseases

Fast-track your pipeline with preclinical excellence. in vitro & in vivo research services since 1991.

Rebalancing the immune system, resolving inflammation.

Connecting Leaders in Pharmaceutical Industry with Leaders in the Scientific Community

Developing Innovative Small-molecule Oral Therapies for Immune-Mediated Inflammatory Diseases, or IMIDs

Targeting GATA-3 for the treatment of chronic inflammatory diseases

Targeted cardiometabolic therapeutics for diabetes and related metabolic conditions

Discovering and developing novel therapies to transform the treatment of cancer and inflammatory disease.